Form 4 for MRNA Moderna
Accepted 2025-08-29 00:00:00 ET · period of report 2025-08-27 · accession 0001127602-25-021026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-08-29 | 2025-08-27+ | MRNA | Hoge Stephen | Pres | M - OptEx | — | +2,048 | 1.45M | +0.1% | — |
| DM | 2025-08-29 | 2025-08-27+ | MRNA | Hoge Stephen | Pres | F - Tax | $24.84 | -991 | 1.45M | -0.1% | -$24.6K |
| DM | 2025-08-29 | 2025-08-27+ | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -2,048 | 3,663 | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-27 | M | A | 1,437 | — | 1,453,556 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2025-08-28 | F | D | 296 | $25.10 | 1,453,176 | D | — | — | |
| 3 | Common | Common Stock | 2025-08-28 | M | A | 611 | — | 1,453,472 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2025-08-27 | F | D | 695 | $24.73 | 1,452,861 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2025-08-27 | M | D | 1,437 | $0.00 | 14,368 | D | — · — to — | 1,437 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 6 | Derivative | Restricted Stock Units | 2025-08-28 | M | D | 611 | $0.00 | 3,663 | D | — · — to — | 611 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F5) 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |